EPGL Medical Invents Smart Epidural Needle, Nerve Ablation And
Trigger Point Treatment Devices
IRVINE, Calif., Aug. 12, 2013 /PRNewswire/ -- EP Global
Communications, Inc. and EPGL Medical (the Company), (OTC-PINK:
EPGL) announced today that Company engineers have invented three
"smart medical devices" which have similar purpose; to give
physicians advanced situational awareness during critical
procedures and thus cutting cost to providers and risk to patients.
These three devices are next for FDA 510k clearance.
"EPGL is a company that is amassing advanced device
technologies at a rapid pace and will make its mark with
development of smarter medical devices." said David T. Markus
PhD. "We have the advantage in advanced MEMS technology and
this is the field that will revolutionize medicine in the next
several years. EPGL shareholders are in a very special
company at a special time."
1. MEMS Epidural Needle Device
EPGL Medical has invented a smart needle for procedures
involving injection of any substance into the epidural space.
These procedures require a physician to be technically proficient
in order to avoid complications. Practitioners commonly use
air or saline for identifying the epidural space.
However, EPGL Medical is using TopSpin micron movement precision
technology with advanced sensors to give the physician better
situational awareness during the procedure.
Physicians have to take great care to avoid puncturing the layer
adjoining the epidural space which contains cerebrospinal fluid
under pressure. If they were to puncture this while threading
the needle between vertebras into the epidural space, it could
cause complications for the patient. EPGL's smart device will
help doctors have much greater situational awareness for this
procedure.
2. MEMS Nerve Ablation Device
EPGL Medical has invented a smarter nerve ablation device.
Radio Frequency Ablation (RFA), is used to produce heat on nerves
surrounding the facet joints on either side of
the lumbar spine. This procedure eliminates the ability
for the nerve to transmit pain signals to the brain, thus giving
the patient temporary relief. In similar fashion to the smart
epidural needle mentioned above, the EPGL trigger point treatment
device advances this ablation tool with TopSpin precision and
sensors, giving the physician better situational awareness during
the procedure and thus less risk of complications.
3. MEMS Trigger Point Needle Device
EPGL Medical has invented a more accurate needle device for
treatment of myofascial trigger points. Injections for
trigger points can be dry or include saline, local
anesthetics such as steroids procaine hydrochloride,
lidocaine, and botulinum toxin to provide more immediate
relief and can be effective when other methods fail. However,
physicians will have a better, more accurate needling device for
treatment of trigger points. The new device will employ advanced
MEMS technology sensors through a TopSpin platform, to more
accurately identify the dimensions and perimeter of the myofascial
trigger points to be injected. The MPD1 is to stimulate the
trigger points and the new MPT1 device will better treat the
trigger points.
About EP Global Communications, Inc. / EPGL Medical
EP Global Communications, Inc. is a medical device manufacturer
and marketing company with a world-class team of doctors and
scientists on board. The Company is currently marketing its
first FDA cleared device with several additional "smart" medical
devices under development. The Company is the owner of the
cutting edge technological platform for medical device development
called "Topspin."
RELATED LINKS
http://www.epglmed.com
SOURCE EPGL Medical